Ganodermanontriol, a lanostanoid triterpene from Ganoderma lucidum, suppresses growth of colon cancer cells through β-catenin signaling

International Journal of Oncology

Volumn 38, Issue 3, 2011, Pages 761-767

  Jedinak, Andrej ^a   Thyagarajan Sahu, Anita ^a   Jiang, Jiahua ^a   Sliva, Daniel ^a,b,c  

^a METHODIST RESEARCH INSTITUTE   (United States)

^b INDIANA UNIVERSITY   (United States)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

catenin; Colon cancer; Cyclin D1; Ganoderma lucidum; Ganodermanontriol

Indexed keywords

BETA CATENIN; CYCLIN D1; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; CYCLIN E; GANODERMANONTRIOL; PROTEIN P21; TRITERPENE DERIVATIVE; UNCLASSIFIED DRUG; UVOMORULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CANCER SIZE; CELL CYCLE ARREST; CELL PROLIFERATION; CELL STRAIN HCT116; CELL VIABILITY; COLON ADENOCARCINOMA; CONTROLLED STUDY; GANODERMA LUCIDUM; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; XENOGRAFT;

ADENOCARCINOMA; ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BETA CATENIN; CELL PROLIFERATION; COLONIC NEOPLASMS; DOWN-REGULATION; FEMALE; HCT116 CELLS; HT29 CELLS; HUMANS; LANOSTEROL; MALE; MICE; MICE, NUDE; REISHI; SIGNAL TRANSDUCTION; TRITERPENES; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 79952025254     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2011.898     Document Type: Article

References (45)

1. Wolpin BM and Mayer RJ: Systemic treatment of colorectal cancer. Gastroenterology 134: 1296-1310, 2008.
2. Jemal A, Siegel R, Xu J and Ward E: Cancer Statistics, 2010. CA Cancer J Clin 60: 277-300, 2010.
3. Giles RH, van Es JH and Clevers H: Caught up in a Wnt storm: Wnt signaling in cancer. Biochim Biophys Acta 1653: 1-24, 2003. (Pubitemid 36627817)
4. Shtutman M, Zhurinsky J, Simcha I, Albanese C, D'Amico M, Pestell R and Ben-Ze'ev A: The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Proc Natl Acad Sci USA 96: 5522-5527, 1999. (Pubitemid 29234650)
5. He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, Morin PJ, Vogelstein B and Kinzler KW: Identification of c-MYC as a target of the APC pathway. Science 281: 1509-1512, 1998. (Pubitemid 28425575)
6. He TC, Chan TA, Vogelstein B and Kinzler KW: PPARdelta is an APC-regulated target of nonsteroidal anti-inflammatory drugs. Cell 99: 335-345, 1999. (Pubitemid 29519912)
7. Tetsu O and McCormick F: Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 398: 422-426, 1999. (Pubitemid 29180374)
8. Yan YX, Nakagawa H, Lee MH and Rustgi AK: Transforming growth factor-alpha enhances cyclin D1 transcription through the binding of early growth response protein to a cis-regulatory element in the cyclin D1 promoter. J Biol Chem 272: 33181-33190, 1997. (Pubitemid 28023664)
9. Arber N, Hibshoosh H, Moss SF, Sutter T, Zhang Y, Begg M, Wang S, Weinstein IB and Holt PR: The PRAD-1/cyclin D1 oncogene product accumulates aberrantly in a subset of colorectal carcinomas. Int J Cancer 58: 568-573, 1994.
10. Freemantle SJ, Liu X, Feng Q, Galimberti F, Blumen S, Sekula D, Kitareewan S, Dragnev KH and Dmitrovsky E: Cyclin degradation for cancer therapy and chemoprevention. J Cell Biochem 102: 869-877, 2007. (Pubitemid 350036927)
11. Zhong JJ and Xiao JH: Secondary metabolites from higher fungi: discovery, bioactivity, and bioproduction. Adv Biochem Eng Biotechnol 113: 79-150, 2009.
12. Weng CJ and Yen GC: The in vitro and in vivo experimental evidences disclose the chemopreventive effects of Ganoderma lucidum on cancer invasion and metastasis. Clin Exp Metastasis 27: 361-369, 2010.
13. Gao JJ, Min BS, Ahn EM, Nakamura N, Lee HK and Hattori M: New triterpene aldehydes, lucialdehydes A-C, from Ganoderma lucidum and their cytotoxicity against murine and human tumor cells. Chem Pharm Bull (Tokyo) 50: 837-840, 2002.
14. Lin SB, Li CH, Lee SS and Kan LS: Triterpene-enriched extracts from Ganoderma lucidum inhibit growth of hepatoma cells via suppressing protein kinase C, activating mitogen-activated protein kinases and G2-phase cell cycle arrest. Life Sci 72: 2381-2390, 2003.
15. Thyagarajan A, Jedinak A, Nguyen H, Terry C, Baldridge LA, Jiang J and Sliva D: Triterpenes from Ganoderma lucidum induce autophagy in colon cancer through the inhibition of p38 mitogen-activated kinase (p38 MAPK). Nutr Cancer 62: 630-640, 2010.
16. Zhu M, Chang Q, Wong LK, Chong FS and Li RC: Triterpene antioxidants from Ganoderma lucidum. Phytother Res 13: 529-531, 1999.
17. Min BS, Nakamura N, Miyashiro H, Bae KW and Hattori M: Triterpenes from the spores of Ganoderma lucidum and their inhibitory activity against HIV-1 protease. Chem Pharm Bull (Tokyo) 46: 1607-1612, 1998.
18. Min BS, Gao JJ, Hattori M, Lee HK and Kim YH: Anticomplement activity of terpenoids from the spores of Ganoderma lucidum. Planta Med 67: 811-814, 2001.
19. Jedinak A and Sliva D: Pleurotus ostreatus inhibits proliferation of human breast and colon cancer cells through p53-dependent as well as p53-independent pathway. Int J Oncol 33: 1307-1313, 2008.
20. Sliva D, Labarrere C, Slivova V, Sedlak M, Lloyd FP Jr and Ho NW: Ganoderma lucidum suppresses motility of highly invasive breast and prostate cancer cells. Biochem Biophys Res Commun 298: 603-612, 2002.
21. Sliva D, Rizzo MT and English D: Phosphatidylinositol 3-kinase and NF-κB regulate motility of invasive MDA-MB-231 human breast cancer cells by the secretion of urokinase-type plasminogen activator (uPA). J Biol Chem 277: 3150-3157, 2002. (Pubitemid 34953176)
22. Orsulic S, Huber O, Aberle H, Arnold S and Kemler R: E-cadherin binding prevents beta-catenin nuclear localization and beta-catenin/LEF-1-mediated transactivation. J Cell Sci 112: 1237-1245, 1999. (Pubitemid 29218912)
23. Sengupta N, Gill KA, MacFie TS, Lai CS, Suraweera N, Mcdonald S and Silver A: Management of colorectal cancer: a role for genetics in prevention and treatment? Pathol Res Pract 204: 469-477, 2008.
24. Wang JJ, Lee JY, Chen YC, Chern YT and Chi CW: The antitumor effect of a novel differentiation inducer, 2, 2-Bis (4-(4-amino-3-hydroxyphenoxy) phenyl) adamantane (DPA), in combinatory therapy on human colon cancer. Int J Oncol 28: 1003-1012, 2006.
25. Petronelli A, Pannitteri G and Testa U: Triterpenoids as new promising anticancer drugs. Anticancer Drugs 20: 880-892, 2009.
26. Jedinak A, Muckova M, Kostalova D, Maliar T and Masterova I: Antiprotease and antimetastatic activity of ursolic acid isolated from Salvia officinalis. Z Naturforsch C 61: 777-782, 2006. (Pubitemid 46159129)
27. Sliva D: Medicinal potential of Ganoderma lucidum. In: Applied Mycology. Rai M and Bridge PD (eds). CAB International, Oxon, Cambridge, pp173-196, 2009.
28. Boh B, Berovic M, Zhang J and Lin ZB: Ganoderma lucidum and its pharmaceutically active compounds. Biotechnol Annu Rev 13: 265-301, 2007.
29. Adamec J, Jannasch A, Dudhgaonkar S, Jedinak A, Sedlak M and Sliva D: Development of a new method for improved identification and relative quantification of unknown metabolites in complex samples: determination of a triterpenoid metabolic fingerprint for the in situ characterization of Ganoderma bioactive compounds. J Sep Sci 32: 4052-4058, 2009.
30. Zhang Q, Zuo F, Nakamura N, Ma CM and Hattori M: Metabolism and pharmacokinetics in rats of ganoderiol F, a highly cytotoxic and antitumor triterpene from Ganoderma lucidum. J Nat Med 63: 304-310, 2009.
31. Jiang J, Grieb B, Thyagarajan A and Sliva D: Ganoderic acids suppress growth and invasive behavior of breast cancer cells by modulating AP-1 and NF-kappaB signaling. Int J Mol Med 21: 577-584, 2008.
32. Liu J, Shiono J, Shimizu K, Kukita A, Kukita T and Kondo R: Ganoderic acid DM: anti-androgenic osteoclastogenesis inhibitor. Bioorg Med Chem Lett 19: 2154-2157, 2009.
33. Tang W, Liu JW, Zhao WM, Wei DZ and Zhong JJ: Ganoderic acid T from Ganoderma lucidum mycelia induces mitochondria mediated apoptosis in lung cancer cells. Life Sci 80: 205-211, 2006.
34. Li CH, Chen PY, Chang UM, Kan LS, Fang WH, Tsai KS and Lin SB: Ganoderic acid X, a lanostanoid triterpene, inhibits topoisomerases and induces apoptosis of cancer cells. Life Sci 77: 252-265, 2005.
35. Hsu CL, Yu YS and Yen GC: Lucidenic acid B induces apoptosis in human leukemia cells via a mitochondria-mediated pathway. J Agric Food Chem 56: 3973-3980, 2008.
36. Nelson WJ and Nusse R: Convergence of Wnt, beta-catenin, and cadherin pathways. Science 303: 1483-1487, 2004. (Pubitemid 38314410)
37. Harris TJ and Peifer M: Decisions, decisions: beta-catenin chooses between adhesion and transcription. Trends Cell Biol 15: 234-237, 2005. (Pubitemid 40603891)
38. Adams CL and Nelson WJ: Cytomechanics of cadherin-mediated cell-cell adhesion. Curr Opin Cell Biol 10: 572-577, 1998. (Pubitemid 28477014)
39. Huber O, Bierkamp C and Kemler R: Cadherins and catenins in development. Curr Opin Cell Biol 8: 685-691, 1996. (Pubitemid 26381726)
40. Huber O, Korn R, McLaughlin J, Ohsugi M, Herrmann BG and Kemler R: Nuclear localization of beta-catenin by interaction with transcription factor LEF-1. Mech Dev 59: 3-10, 1996. (Pubitemid 26325455)
41. Yamada S, Pokutta S, Drees F, Weis WI and Nelson WJ: Deconstructing the cadherin-catenin-actin complex. Cell 123: 889-901, 2005. (Pubitemid 41721034)
42. Perl AK, Wilgenbus P, Dahl U, Semb H and Christofori G: A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature 392: 190-193, 1998. (Pubitemid 28162793)
43. Pálmer HG, González-Sancho JM, Espada J, Berciano MT, Puig I, Baulida J, Quintanilla M, Cano A, de Herreros AG, Lafarga M and Muñoz A: Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of beta-catenin signaling. J Cell Biol 154: 369-387, 2001.
44. Meng Q, Qi M, Chen DZ, Yuan R, Goldberg ID, Rosen EM, Auborn K and Fan S: Suppression of breast cancer invasion and migration by indole-3-carbinol: associated with up-regulation of BRCA1 and E-cadherin/catenin complexes. J Mol Med 78: 155-165, 2000. (Pubitemid 30337497)
45. Brack ME, Boterberg T, Depypere HT, Stove C, Leclercq G and Mareel MM: The citrus methoxyflavone tangeretin affects human cell-cell interactions. Adv Exp Med Biol 505: 135-139, 2002. (Pubitemid 34526430)